Claudia Raineri

ORCID: 0000-0001-9653-1516
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac Imaging and Diagnostics
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Effects of Exercise
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Mechanical Circulatory Support Devices
  • Viral Infections and Immunology Research
  • Heart Failure Treatment and Management
  • Transplantation: Methods and Outcomes
  • Congenital Heart Disease Studies
  • Cardiovascular Issues in Pregnancy
  • Infective Endocarditis Diagnosis and Management
  • Eosinophilic Disorders and Syndromes
  • Cardiac Arrest and Resuscitation
  • Heart Rate Variability and Autonomic Control
  • Advanced MRI Techniques and Applications
  • Nuclear Structure and Function
  • Vascular Anomalies and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Aortic Disease and Treatment Approaches

University of Turin
2021-2025

Fondazione Ricerca Molinette
2020-2025

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2021-2025

Policlinico San Matteo Fondazione
2014-2023

Istituti di Ricovero e Cura a Carattere Scientifico
2013-2023

University of Pavia
2001-2023

Humanitas Mater Domini
2023

University of Milan
2023

Azienda Ospedaliero Universitaria San Giovanni Battista
2023

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2017

There is controversy about the outcome of patients with acute myocarditis (AM), and data are lacking on how admitted suspected AM managed. We report characteristics, in-hospital management, long-term based a retrospective multicenter registry from 19 Italian hospitals.A total 684 recent onset symptoms (<30 days) were screened between May 2001 February 2017. Patients >70 years age those >50 without coronary angiography excluded. The final study population comprised 443 (median age, 34 years;...

10.1161/circulationaha.118.035319 article EN Circulation 2018-05-15

Previous reports have suggested that despite their dramatic presentation, patients with fulminant myocarditis (FM) might better outcome than those acute nonfulminant (NFM). In this retrospective study, we report and changes in left ventricular ejection fraction (LVEF) a large cohort of FM compared NFM.The study population consists 187 consecutive admitted between May 2001 November 2016 diagnosis (onset symptoms <1 month) whom 55 required inotropes and/or mechanical circulatory support the...

10.1161/circulationaha.117.026386 article EN Circulation 2017-06-03

Accurate risk stratification for patients with non-dilated left ventricular cardiomyopathy (NDLVC) remains challenging due to lack of dedicated clinical trials. This post-hoc analysis aims delineate the arrhythmic and assess incremental value cardiac magnetic resonance (CMR) imaging in DERIVATE (CarDiac MagnEtic Resonance Primary Prevention Implantable CardioVerter DebrillAtor ThErapy) study cohort meeting NDLVC diagnostic criteria. Patients from registry were identified absence (LV)...

10.1093/ehjci/jeaf043 article EN cc-by European Heart Journal - Cardiovascular Imaging 2025-02-03

AimsTo assess the relationship between cardiovascular magnetic resonance (CMR) parameters and both spontaneous ventricular tachycardia (VT) risk of sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) patients.

10.1093/eurheartj/ehp152 article EN European Heart Journal 2009-05-27

The assessment of post-myocardial infarction (MI) left ventricular (LV) remodeling by cardiovascular magnetic resonance (CMR) currently uses criteria defined echocardiography. Our aim was to provide CMR for assessing LV following acute MI. Firstly, 40 reperfused ST-segment elevation myocardial (STEMI) patients with paired (4 ± 2 days) and follow-up (5 months) scans were analyzed independent reviewers the minimal detectable changes (MDCs) percentage change in end-diastolic volume (%ΔLVEDV),...

10.1186/s12968-017-0343-9 article EN cc-by Journal of Cardiovascular Magnetic Resonance 2016-12-01

The aim of this registry was to evaluate the additional prognostic value a composite cardiac magnetic resonance (CMR)-based risk score over standard-of-care (SOC) evaluation in large cohort consecutive unselected non-ischaemic cardiomyopathy (NICM) patients.In DERIVATE (www.clinicaltrials.gov/registration: RCT#NCT03352648), 1000 (derivation cohort) and 508 (validation NICM patients with chronic heart failure (HF) left ventricular ejection fraction <50% were included. All-cause mortality...

10.1093/europace/euaa401 article EN EP Europace 2020-12-06

Aims In the EXPLORER‐HCM trial, mavacamten reduced left ventricular outflow tract obstruction (LVOTO) and improved functional capacity of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) patients. We sought to define potential use by comparing real‐world HOCM patients with those enrolled in assessing their eligibility treatment. Methods results collected information on followed up at 25 Italian HCM outpatient clinics significant LVOTO (i.e. gradient ≥30 mmHg rest or ≥50 after...

10.1002/ejhf.3120 article EN cc-by-nc European Journal of Heart Failure 2023-12-22

Abstract Aims Haemodynamic assessment can be determinant in phenotyping cardiogenic shock (CS) and guiding patient management. Aim of this study was to evaluate the correlation between echocardiographic invasive haemodynamics acute decompensated heart failure-related CS (ADHF-CS). Methods results All consecutive ADHF-CS patients (SCAI stage ≥B) undergoing right catheterization (RHC) 2020 2022 were prospectively enrolled. Patients underwent echocardiography 30 min before RHC. The evaluated...

10.1093/ehjacc/zuae087 article EN European Heart Journal Acute Cardiovascular Care 2024-07-16

Objective To evaluate the prognostic significance of right ventricular function assessed by echocardiography after start or escalation targeted therapy in patients with pulmonary arterial hypertension. Methods Study design: longitudinal study. Setting: tertiary referral centre for Patients: 81 consecutive hypertension (33 naive and 48 prevalent). Interventions: heart catheterisation performed prior to starting escalating repeated 55 4–12 months therapy. Main outcome measure: survival...

10.1136/openhrt-2016-000408 article EN cc-by-nc Open Heart 2016-05-01

Cardiac laminopathies encompass a wide range of diseases caused by defects in nuclear envelope proteins, including cardiomyopathy, atrial and ventricular arrhythmias conduction system abnormalities. Two genes, namely LMNA EMD, are typically associated with these disorders part the routine genetic panel performed affected patients. Yet, there other markedly fewer known nesprins, encoded SYNE that play pivotal role connecting to cytoskeletal elements. So far, gene variants have been described...

10.3390/cardiogenetics15010002 article EN cc-by Cardiogenetics 2025-01-20
Coming Soon ...